Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Eukaryotic Gene Expression
Factor de Impacto: 1.841 Factor de Impacto de 5 años: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2018021528
pages 73-86

Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications

Nida Noreen
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Pakistan
Faqir Muhammad
Institute of Pharmacy, Physiology and Pharmacology, Faculty of Veterinary Science, University of Agriculture, Faisalabad, Pakistan
Bushra Akhtar
Institute of Pharmacy, Physiology and Pharmacology, Faculty of Veterinary Science, University of Agriculture, Faisalabad, Pakistan
Farooq Azam
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Pakistan
Muhammad Irfan Anwar
Faculty of Veterinary Science, Bahauddin Zakariya University, Multan, Pakistan

SINOPSIS

The pharmacological importance of cannabidiol (CBD) has been in study for several years. CBD is the major nonpsychoactive constituent of plant Cannabis sativa and its administration is associated with reduced side effects. Currently, CBD is undergoing a lot of research which suggests that it has no addictive effects, good safety profile and has exhibited powerful therapeutic potential in several vital areas. It has wide spectrum of action because it acts through endocannabinoid receptors; CB1 and CB2 and it also acts on other receptors, such as GPR18, GPR55, GPR 119, 5HT1A, and TRPV2. This indicates its therapeutic value for numerous medical conditions because of its neuroprotective and immunomodulatory properties. Potential therapeutic applications of CBD include, analgesic, anti-inflammatory, anxiolytic, anti-arthritic, anti-depressant, anti-Alzheimer disease, anti-ischemic, neuroprotective, and anti-fibrotic. More promising areas appear to include diabetes and cancer where CBD exhibits lesser side effects and more therapeutic benefits as compared to recent available medical therapies. Hence, CBD is a promising substance for the development of new drug. However further research and clinical studies are required to explore its complete potential.


Articles with similar content:

Morphinan Neuroprotection: New Insight into the Therapy of Neurodegeneration
Critical Reviews™ in Neurobiology, Vol.16, 2004, issue 4
Jau-Shyong Hong, Hyoung-Chun Kim, Michelle L. Block, Wei Zhang, Wanqin Zhang
Recent Advances in Treating Patients with Attention Deficit Hyperactivity Disorder: A Review of Nonpharmacological Interventions
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.31, 2019, issue 3
Abhishek Achunair, Hussain Mansour Tairan
The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 10
Martina Cizmarikova
Recent Advances in Cannabis Addiction and Rehabilitation: A Review
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.28, 2016, issue 1-2
Jagadish V. Kamath, Prabhakara Prabhu, Akarsha Venkateshwara Bhat Mairaje
A Noradrenergic and Serotonergic Hypothesis of the Linkage Between Epilepsy and Affective Disorders
Critical Reviews™ in Neurobiology, Vol.13, 1999, issue 4
John W. Dailey, Phillip C. Jobe, Joe F. Wernicke